Formulary Search

You are here : Home > Formulary Search

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Return to the search options.

A-Z of Drugs : A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

A-Z of Drugs

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Search Results : Nausea and vomiting (chemotherapy induced) (Ondansetron hydrochloride - Nausea and vomiting (chemotherapy induced))

Records returned : 20 (on 29 May 2025 at 13:06:22). Return to search results for ' Nausea and vomiting (chemotherapy induced) '.

Show Icon and Status Keys Hide Icon and Status Keys

Icon Key

NFD1

Non formulary

NFD2

Not assessed for formulary status. Apply to APC / DTC before use.

Controlled drug. Prescribing and/or storage requirements may apply

Restrictions apply

Safety Alert

Unlicensed - no UK marketing license in place

Off-label use. Not licensed for this indication.

NHSE

Treatment commissioned by NHS England

CDF

Cancer Drugs Fund

ICB

Treatment commissioned by the ICB

BlueTeq form to be completed

NICE

Link to the NICE website

Low carbon device

Status Key

Red

Specialist ONLY drugs - treatment initiated and continued by specialist clinicians

Amber

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care under a formal shared care agreement

Green

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing.

Green (see narrative)

GPs (or non-medical prescribers in primary care) are able to take full responsibility for initiation and continuation of prescribing. Please refer to the narrative on the Drug Profile page where additional information may be conveyed as to the place in therapy or restrictions for use that have been locally agreed.

Non Formulary

Not recommended for use in any health setting across the Surrey Heartlands Integrated Care System

Blue

Prescribing initiated and stabilised by specialist but has potential to transfer to primary care WITHOUT a formal shared care agreement. Please note that in some circumstances a specialist may recommend that prescribing can be started in primary care.

See narrative

See narrative - may be applied in instances where a traffic light status has not yet been agreed but an entry to the formulary has been made to clarify interim arrangements.

Drug

Indication

Status

Restrictions/Comments

Formulary Status

Links

1. Ondansetron hydrochloride

Drug:

Ondansetron hydrochloride

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Blue

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Important

Oral solution reserved for use when tablets are not suitable. On request from the specialist / Cancer Centre

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

2. Ondansetron hydrochloride

Drug:

Ondansetron hydrochloride

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Blue

Formulations :

Oro-dispersible
Orodispersible films

Restrictions / Comments:

Important

Orodispersible preparations reserved for use when ordinary tablets are not suitable. On request from the specialist / Cancer Centre

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

3. Ondansetron hydrochloride

Drug:

Ondansetron hydrochloride

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

4. Cyclizine hydrochloride

Drug:

Cyclizine hydrochloride

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Blue

Formulations :

Tablets

Restrictions / Comments:

Important

On request from the specialist / Cancer Centre.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

9. Cyclizine hydrochloride

Drug:

Cyclizine hydrochloride

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

5. Dexamethasone

Drug:

Dexamethasone

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Blue

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Important

On request from the specialist / Cancer Centre

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

10. Dexamethasone

Drug:

Dexamethasone

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

6. Domperidone

Drug:

Domperidone

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Blue

Formulations :

Oral suspension
Tablets

Restrictions / Comments:

Important

Off-label use. On request from the specialist / Cancer Centre

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

7. Metoclopramide hydrochloride

Drug:

Metoclopramide hydrochloride

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Blue

Formulations :

Oral solution
Tablets

Restrictions / Comments:

Important

On request from the specialist / Cancer Centre

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

8. Aprepitant

Drug:

Aprepitant

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Red

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

11. Fosaprepitant

Drug:

Fosaprepitant

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Red

Formulations :

Intravenous infusion

Restrictions / Comments:

Important

RSCH Oncology Team only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

12. Haloperidol

Drug:

Haloperidol

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Red

Formulations :

Injection
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

13. Levomepromazine hydrochloride

Drug:

Levomepromazine hydrochloride

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Important

6mg or 6.25mg tablets for chemo-related nausea and vomiting. ASPH restricted use - 6mg tablets for paediatric oncology only

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

14. Levomepromazine hydrochloride

Drug:

Levomepromazine hydrochloride

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Red

Formulations :

Injection

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

15. Olanzapine

Drug:

Olanzapine

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Red

Formulations :

Oro-dispersible
Tablets

Restrictions / Comments:

Important

Off-label use.

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

16. Prochlorperazine maleate

Drug:

Prochlorperazine maleate

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Red

Formulations :

Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

17. Granisetron

Drug:

Granisetron

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Non Formulary

Formulations :

Injection
Patches
Tablets

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

18. Nabilone

Drug:

Nabilone

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Non Formulary

Formulations :

Capsules

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

19. Palonosetron hydrochloride

Drug:

Palonosetron hydrochloride

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Non Formulary

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1

20. Palonosetron with netupitant

Drug:

Palonosetron with netupitant

Indication :

Nausea and vomiting (chemotherapy induced)

Status :

Non Formulary

Formulations :

Not Specified

Restrictions / Comments:

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Links :

SPC

NFD1